Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Oct;67(792):931–937. doi: 10.1136/pgmj.67.792.931

Treatment of diabetes: the effect on serum lipids and lipoproteins.

P K Merrin 1, R S Elkeles 1
PMCID: PMC2399162  PMID: 1758807

Full text

PDF
931

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagdade J. D., Buchanan W. E., Levy R. A., Subbaiah P. V., Ritter M. C. Effects of omega-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM. Diabetes. 1990 Apr;39(4):426–431. doi: 10.2337/diab.39.4.426. [DOI] [PubMed] [Google Scholar]
  2. Bagdade J. D., Porte D., Jr, Bierman E. L. Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med. 1967 Feb 23;276(8):427–433. doi: 10.1056/NEJM196702232760802. [DOI] [PubMed] [Google Scholar]
  3. Baynes C., Feher M. D., Elkeles R. S. The effect of treatment of non-insulin-dependent diabetes mellitus (NIDDM) on serum lipids and lipoproteins. Q J Med. 1989 Jul;72(267):579–587. [PubMed] [Google Scholar]
  4. Berry E. M., Bar-on H. Comparison on sulphonylurea and insulin treatment on lipid levels in maturity-onset diabetic men and women. Isr J Med Sci. 1981 May;17(5):384–387. [PubMed] [Google Scholar]
  5. Bierman E. L., Amaral J. A., Belknap B. H. Hyperlipemia and diabetes mellitus. Diabetes. 1966 Sep;15(9):675–679. doi: 10.2337/diab.15.9.675. [DOI] [PubMed] [Google Scholar]
  6. Blankenhorn D. H., Nessim S. A., Johnson R. L., Sanmarco M. E., Azen S. P., Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987 Jun 19;257(23):3233–3240. [PubMed] [Google Scholar]
  7. Borch-Johnsen K., Andersen P. K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985 Aug;28(8):590–596. doi: 10.1007/BF00281993. [DOI] [PubMed] [Google Scholar]
  8. Borch-Johnsen K., Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987 Jun 27;294(6588):1651–1654. doi: 10.1136/bmj.294.6588.1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Calvert G. D., Graham J. J., Mannik T., Wise P. H., Yeates R. A. Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet. 1978 Jul 8;2(8080):66–68. doi: 10.1016/s0140-6736(78)91380-6. [DOI] [PubMed] [Google Scholar]
  10. Coulston A. M., Hollenbeck C. B., Swislocki A. L., Chen Y. D., Reaven G. M. Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med. 1987 Feb;82(2):213–220. doi: 10.1016/0002-9343(87)90058-1. [DOI] [PubMed] [Google Scholar]
  11. Dunn F. L., Pietri A., Raskin P. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus. Ann Intern Med. 1981 Oct;95(4):426–431. doi: 10.7326/0003-4819-95-4-426. [DOI] [PubMed] [Google Scholar]
  12. Dupree E. A., Meyer M. B. Role of risk factors in complications of diabetes mellitus. Am J Epidemiol. 1980 Jul;112(1):100–112. doi: 10.1093/oxfordjournals.aje.a112959. [DOI] [PubMed] [Google Scholar]
  13. ENTMACHER P. S., ROOT H. F., MARKS H. H. LONGEVITY OF DIABETIC PATIENTS IN RECENT YEARS. Diabetes. 1964 Jul-Aug;13:373–377. doi: 10.2337/diab.13.4.373. [DOI] [PubMed] [Google Scholar]
  14. Eckel R. H., Albers J. J., Cheung M. C., Wahl P. W., Lindgren F. T., Bierman E. L. High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes. 1981 Feb;30(2):132–138. doi: 10.2337/diab.30.2.132. [DOI] [PubMed] [Google Scholar]
  15. Elkeles R. S., Wu J., Hambley J. Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetics. Lancet. 1978 Sep 9;2(8089):547–549. doi: 10.1016/s0140-6736(78)92882-9. [DOI] [PubMed] [Google Scholar]
  16. Falko J. M., O'Dorisio T. M., Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 1;247(1):37–39. [PubMed] [Google Scholar]
  17. Falko J. M., Osei K. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med. 1985 Sep 20;79(3B):92–101. doi: 10.1016/s0002-9343(85)80014-0. [DOI] [PubMed] [Google Scholar]
  18. Fontbonne A., Eschwège E., Cambien F., Richard J. L., Ducimetière P., Thibult N., Warnet J. M., Claude J. R., Rosselin G. E. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia. 1989 May;32(5):300–304. doi: 10.1007/BF00265546. [DOI] [PubMed] [Google Scholar]
  19. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  20. Fuessl H. S., Williams G., Adrian T. E., Bloom S. R. Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patients. Diabet Med. 1987 Sep-Oct;4(5):463–468. doi: 10.1111/j.1464-5491.1987.tb00910.x. [DOI] [PubMed] [Google Scholar]
  21. Garg A., Grundy S. M. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 Jan 14;318(2):81–86. doi: 10.1056/NEJM198801143180204. [DOI] [PubMed] [Google Scholar]
  22. Goldberg R., La Belle P., Zupkis R., Ronca P. Comparison of the effects of lovastatin and gemfibrozil on lipids and glucose control in non-insulin-dependent diabetes mellitus. Am J Cardiol. 1990 Sep 18;66(8):16B–21B. doi: 10.1016/0002-9149(90)90436-5. [DOI] [PubMed] [Google Scholar]
  23. Gonen B., White N., Schonfeld G., Skor D., Miller P., Santiago J. Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control. Metabolism. 1985 Jul;34(7):675–679. doi: 10.1016/0026-0495(85)90097-6. [DOI] [PubMed] [Google Scholar]
  24. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann Intern Med. 1977 Oct;87(4):393–397. doi: 10.7326/0003-4819-87-4-393. [DOI] [PubMed] [Google Scholar]
  25. Greenfield M. S., Doberne L., Rosenthal M., Vreman H. J., Reaven G. M. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy. Arch Intern Med. 1982 Aug;142(8):1498–1500. [PubMed] [Google Scholar]
  26. Hockaday T. D. Fibre in the management of diabetes. 1. Natural fibre useful as part of total dietary prescription. BMJ. 1990 May 19;300(6735):1334–1336. doi: 10.1136/bmj.300.6735.1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hollenbeck C. B., Chen Y. D., Greenfield M. S., Lardinois C. K., Reaven G. M. Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1986 Mar;62(3):605–608. doi: 10.1210/jcem-62-3-605. [DOI] [PubMed] [Google Scholar]
  28. Hollenbeck C. B., Connor W. E., Riddle M. C., Alaupovic P., Leklem J. E. The effects of a high-carbohydrate low-fat cholesterol-restricted diet on plasma lipid, lipoprotein, and apoprotein concentrations in insulin-dependent (type I) diabetes mellitus. Metabolism. 1985 Jun;34(6):559–566. doi: 10.1016/0026-0495(85)90194-5. [DOI] [PubMed] [Google Scholar]
  29. Janka H. U. Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metab Res Suppl. 1985;15:15–19. [PubMed] [Google Scholar]
  30. Jenkins D. J., Wolever T. M., Taylor R. H., Reynolds D., Nineham R., Hockaday T. D. Diabetic glucose control, lipids, and trace elements on long-term guar. Br Med J. 1980 Jun 7;280(6228):1353–1354. doi: 10.1136/bmj.280.6228.1353-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jensen T., Borch-Johnsen K., Kofoed-Enevoldsen A., Deckert T. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia. 1987 Mar;30(3):144–148. doi: 10.1007/BF00274218. [DOI] [PubMed] [Google Scholar]
  32. Jensen T., Stender S., Goldstein K., Hølmer G., Deckert T. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N Engl J Med. 1989 Dec 7;321(23):1572–1577. doi: 10.1056/NEJM198912073212304. [DOI] [PubMed] [Google Scholar]
  33. Jones S. L., Close C. F., Mattock M. B., Jarrett R. J., Keen H., Viberti G. C. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ. 1989 Feb 25;298(6672):487–490. doi: 10.1136/bmj.298.6672.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  35. Kaufmann R. L., Assal JPh, Soeldner J. S., Wilmshurst E. G., Lemaire J. R., Gleason R. E., White P. Plasma lipid levels in diabetic children. Effect of diet restricted in cholesterol and saturated fats. Diabetes. 1975 Jul;24(7):672–679. doi: 10.2337/diab.24.7.672. [DOI] [PubMed] [Google Scholar]
  36. Kennedy L., Walshe K., Hadden D. R., Weaver J. A., Buchanan K. D. The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with Type 2 (non-insulin-dependent) diabetes mellitus: a prospective study. Diabetologia. 1982 Jul;23(1):24–27. doi: 10.1007/BF00257725. [DOI] [PubMed] [Google Scholar]
  37. Kilo C., Miller J. P., Williamson J. R. The crux of the UGDP. Spurious results and biologically inappropriate data analysis. Diabetologia. 1980 Mar;18(3):179–185. doi: 10.1007/BF00251913. [DOI] [PubMed] [Google Scholar]
  38. Krolewski A. S., Kosinski E. J., Warram J. H., Leland O. S., Busick E. J., Asmal A. C., Rand L. I., Christlieb A. R., Bradley R. F., Kahn C. R. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 1987 Apr 1;59(8):750–755. doi: 10.1016/0002-9149(87)91086-1. [DOI] [PubMed] [Google Scholar]
  39. Laakso M., Rönnemaa T., Pyörälä K., Kallio V., Puukka P., Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988 Jun;11(6):449–463. doi: 10.2337/diacare.11.6.449. [DOI] [PubMed] [Google Scholar]
  40. Laakso M., Voutilainen E., Sarlund H., Aro A., Pyörälä K., Penttilä I. Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics. Metabolism. 1985 Aug;34(8):715–720. doi: 10.1016/0026-0495(85)90020-4. [DOI] [PubMed] [Google Scholar]
  41. Lalor B. C., Bhatnagar D., Winocour P. H., Ishola M., Arrol S., Brading M., Durrington P. N. Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients. Diabet Med. 1990 Mar-Apr;7(3):242–245. doi: 10.1111/j.1464-5491.1990.tb01378.x. [DOI] [PubMed] [Google Scholar]
  42. Lindström T., Arnqvist H. J., Olsson A. G. Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis. 1990 Mar;81(2):137–144. doi: 10.1016/0021-9150(90)90020-j. [DOI] [PubMed] [Google Scholar]
  43. Lisch H. J., Sailer S. Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics. Diabetologia. 1981 Feb;20(2):118–122. doi: 10.1007/BF00262013. [DOI] [PubMed] [Google Scholar]
  44. Lopes-Virella M. F., Wohltmann H. J., Loadholt C. B., Buse M. G. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia. 1981 Sep;21(3):216–223. doi: 10.1007/BF00252657. [DOI] [PubMed] [Google Scholar]
  45. Lopes-Virella M. F., Wohltmann H. J., Mayfield R. K., Loadholt C. B., Colwell J. A. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients. A longitudinal study. Diabetes. 1983 Jan;32(1):20–25. doi: 10.2337/diab.32.1.20. [DOI] [PubMed] [Google Scholar]
  46. Mori T. A., Vandongen R., Masarei J. R. Fish oil-induced changes in apolipoproteins in IDDM subjects. Diabetes Care. 1990 Jul;13(7):725–732. doi: 10.2337/diacare.13.7.725. [DOI] [PubMed] [Google Scholar]
  47. Nikkilä E. A. High density lipoproteins in diabetes. Diabetes. 1981;30(Suppl 2):82–87. [PubMed] [Google Scholar]
  48. Nikkilä E. A., Hormila P. Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes. 1978 Nov;27(11):1078–1086. doi: 10.2337/diab.27.11.1078. [DOI] [PubMed] [Google Scholar]
  49. Ostlund R. E., Jr, Semenkovich C. F., Schechtman K. B. Quantitative relationship between plasma lipids and glycohemoglobin in type I patients. Longitudinal study of 212 patients. Diabetes Care. 1989 May;12(5):332–336. doi: 10.2337/diacare.12.5.332. [DOI] [PubMed] [Google Scholar]
  50. Paisey R., Elkeles R. S., Hambley J., Magill P. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia. 1978 Aug;15(2):81–85. doi: 10.1007/BF00422249. [DOI] [PubMed] [Google Scholar]
  51. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987 Mar;30(3):123–131. doi: 10.1007/BF00274216. [DOI] [PubMed] [Google Scholar]
  52. Pietri A., Dunn F. L., Raskin P. The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion. Diabetes. 1980 Dec;29(12):1001–1005. doi: 10.2337/diab.29.12.1001. [DOI] [PubMed] [Google Scholar]
  53. Rains S. G., Wilson G. A., Richmond W., Elkeles R. S. The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med. 1988 Oct;5(7):653–658. doi: 10.1111/j.1464-5491.1988.tb01074.x. [DOI] [PubMed] [Google Scholar]
  54. Rains S. G., Wilson G. A., Richmond W., Elkeles R. S. The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy. J R Soc Med. 1989 Feb;82(2):93–94. doi: 10.1177/014107688908200213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Reckless J. P., Betteridge D. J., Wu P., Payne B., Galton D. J. High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J. 1978 Apr 8;1(6117):883–886. doi: 10.1136/bmj.1.6117.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Riccardi G., Rivellese A., Pacioni D., Genovese S., Mastranzo P., Mancini M. Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia. 1984 Feb;26(2):116–121. doi: 10.1007/BF00281117. [DOI] [PubMed] [Google Scholar]
  57. Rosengren A., Welin L., Tsipogianni A., Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ. 1989 Nov 4;299(6708):1127–1131. doi: 10.1136/bmj.299.6708.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. STONE D. B., CONNOR W. E. The prolonged effects of a low cholesterol, high carbohydrate diet upon the serum lipids in diabetic patients. Diabetes. 1963 Mar-Apr;12:127–132. doi: 10.2337/diab.12.2.127. [DOI] [PubMed] [Google Scholar]
  59. Santen R. J., Willis P. W., 3rd, Fajans S. S. Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level. Arch Intern Med. 1972 Dec;130(6):833–843. doi: 10.1001/archinte.130.6.833. [DOI] [PubMed] [Google Scholar]
  60. Semenkovich C. F., Ostlund R. E., Jr, Schechtman K. B. Plasma lipids in patients with type I diabetes mellitus. Influence of race, gender, and plasma glucose control: lipids do not correlate with glucose control in black women. Arch Intern Med. 1989 Jan;149(1):51–56. [PubMed] [Google Scholar]
  61. Seviour P. W., Teal T. K., Richmond W., Elkeles R. S. Chlorpropamide lowers serum and lipoprotein cholesterol in insulin-dependent diabetes. Diabet Med. 1986 Mar;3(2):152–154. doi: 10.1111/j.1464-5491.1986.tb00727.x. [DOI] [PubMed] [Google Scholar]
  62. Seviour P. W., Teal T. K., Richmond W., Elkeles R. S. Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med. 1988 Mar;5(2):166–171. doi: 10.1111/j.1464-5491.1988.tb00965.x. [DOI] [PubMed] [Google Scholar]
  63. Sirtori C. R., Tremoli E., Sirtori M., Conti F., Paoletti R. Treatment of hypertriglyceridemia with metformin. Effectiveness and analỳsis of results. Atherosclerosis. 1977 Apr;26(4):583–592. doi: 10.1016/0021-9150(77)90125-3. [DOI] [PubMed] [Google Scholar]
  64. Sosenko J. M., Breslow J. L., Miettinen O. S., Gabbay K. H. Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med. 1980 Mar 20;302(12):650–654. doi: 10.1056/NEJM198003203021202. [DOI] [PubMed] [Google Scholar]
  65. Stacpoole P. W., Alig J., Ammon L., Crockett S. E. Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia. Metabolism. 1989 Oct;38(10):946–956. doi: 10.1016/0026-0495(89)90004-8. [DOI] [PubMed] [Google Scholar]
  66. Tattersall R., Mansell P. Fibre in the management of diabetes. 2. Benefits of fibre itself are uncertain. BMJ. 1990 May 19;300(6735):1336–1337. doi: 10.1136/bmj.300.6735.1336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Taylor K. G., John W. G., Matthews K. A., Wright A. D. A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes. Diabetologia. 1982 Dec;23(6):507–510. doi: 10.1007/BF00254300. [DOI] [PubMed] [Google Scholar]
  68. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984 Jan 20;251(3):365–374. [PubMed] [Google Scholar]
  69. Vannini P., Ciavarella A., Flammini M., Bargossi A. M., Forlani G., Borgnino L. C., Orsoni G. Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care. 1984 Mar-Apr;7(2):151–154. doi: 10.2337/diacare.7.2.151. [DOI] [PubMed] [Google Scholar]
  70. Walden C. E., Knopp R. H., Wahl P. W., Beach K. W., Strandness E., Jr Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med. 1984 Oct 11;311(15):953–959. doi: 10.1056/NEJM198410113111505. [DOI] [PubMed] [Google Scholar]
  71. Weidman S. W., Ragland J. B., Fisher J. N., Jr, Kitabchi A. E., Sabesin S. M. Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment. J Lipid Res. 1982 Jan;23(1):171–182. [PubMed] [Google Scholar]
  72. Winocour P. H., Durrington P. N., Bhatnagar D., Ishola M., Arrol S., Lalor B. C., Anderson D. C. Double-blind placebo-controlled study of the effects of bezafibrate on blood lipids, lipoproteins, and fibrinogen in hyperlipidaemic type 1 diabetes mellitus. Diabet Med. 1990 Sep-Oct;7(8):736–743. doi: 10.1111/j.1464-5491.1990.tb01479.x. [DOI] [PubMed] [Google Scholar]
  73. Winocour P. H., Durrington P. N., Ishola M., Anderson D. C., Cohen H. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987 Jun 27;294(6588):1648–1651. doi: 10.1136/bmj.294.6588.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Winocour P. H., Durrington P. N., Ishola M., Anderson D. C. Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet. 1986 May 24;1(8491):1176–1178. doi: 10.1016/s0140-6736(86)91159-1. [DOI] [PubMed] [Google Scholar]
  75. Winocour P. H., Durrington P. N., Ishola M., Hillier V. F., Anderson D. C. The prevalence of hyperlipidaemia and related clinical features in insulin-dependent diabetes mellitus. Q J Med. 1989 Mar;70(263):265–276. [PubMed] [Google Scholar]
  76. Winocour P. H., Laker M. F. Drug therapy for diabetic dyslipoproteinaemia: a practical approach. Diabet Med. 1990 May;7(4):292–298. doi: 10.1111/j.1464-5491.1990.tb01392.x. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES